Explore announcements, event recaps, venture success stories, thought leadership from around the Polsky Center innovation ecosystem, and more.
Dr. Elliott Sigal (MD’81, PhD), President of R&D;, Bristol-Myers Squibb, and Dr. Michael Prystowsky (MD’81, PhD), Chairman of Pathology, Albert Einstein College of Medicine, participate in the inaugural event of...
In the vanguard of a new generation of promising drug therapies for treating atherosclerosis with “good” cholesterol (high density lipoprotein, or HDL) is an agent being developed by Godfrey Getz,...
It’s no surprise that Intellectual Ventures, a leading global investor in inventions, hired Karen Kerr, PhD, to forge relationships with universities doing innovative translational research. After all, the recently appointed U.S....
A few years ago, University of Chicago alumnus Martin E. Sanders, MD ’79, attended a “meet and greet” in San Francisco that was held to introduce the University’s new President Robert...
Solarmer Energy Inc. is developing plastic solar cells for portable electronic devices that will incorporate technology invented at the University of Chicago. The company is on track to complete a...
Arryx, a company based on technology invented at the University of Chicago that still has strong ties with the University, is poised to help Haemonetics, the world’s largest manufacturer of automated blood processing...
Generating electrical power from the sun and the wind share a common drawback: The sun does not always shine and the wind does not always blow when and where the...
Time. Treasure. Talent. That’s what alumni should give back to their schools, according to Doug Given, an Investment Partner at Bay City Capital and longtime advisor to UChicagoTech—the University of Chicago’s Office...
On August 20, Chromatin—a company that grew out of research at the University of Chicago—announced that it had entered into a technological alliance and license agreement with Bayer CropScience. Under the agreement, Bayer...
UChicagoTech, the University of Chicago’s Office of Technology and Intellectual Property, recently conducted its second in a series of Translation Events that bring industry experts to campus to advise faculty...
By the end of the year, Midway Pharmaceuticals expects to have successfully navigated the “Valley of Death.” That’s the period of financing between identifying a drug product candidate and getting...
Timing is everything, and Norm Winarsky figures it’s his time to act.“At this time in my life, I feel as though I have the opportunity to make a bigger impact...